pharma Archives - Kotter International Inc

Counterfeit drugs are rising as viral demand outpaces regulation. Learn how pharma leaders can protect trust, safety, and innovation.

Blog EMEA Innovation Kotter In The News Kotter Insights Leadership Development Pharma + Biotech

Question of Trust: How Pharma Leaders Can Respond to Counterfeit Drug Risk

The news that Hein Schumacher is set to take over from Barry Callebaut CEO Peter…

Nick PetschekFebruary 2, 2026

Pharmaceutical R+D has never been more technologically capable. Artificial analytics are accelerating discovery cycles in ways that were unimaginable a decade ago. Yet despite these advances, sustaining innovation has become harder than ever. Development costs are climbing, competition for talent is intensifying and many of the most exciting early-stage innovations are now coming from biotech and academic partners. At the same time, a new generation of scientists is entering the field with different expectations. They look for trust, adaptability and purpose, not rigid hierarchies and incremental progress.

Blog Culture Change EMEA Innovation Kotter In The News Kotter Insights Leadership Development Pharma + Biotech

The Future of Pharma R+D Leadership

Pharmaceutical R+D has never been more technologically capable. Artificial analytics are accelerating discovery cycles in…

Nick PetschekJanuary 27, 2026